SCHEMBL660301

SCHEMBL660301

N#Cc1sc2cnccc2c1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.38
NCOA3 Q9Y6Q9 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
NCOA1 Q15788 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RCE1 Q9Y256 1/20 0.37
IMPDH2 P12268 1/20 0.35
CHUK O15111 1/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
AXL P30530 1/20 0.33
KDM5A P29375 1/20 0.32
KDM5C P41229 1/20 0.32
KDM5B Q9UGL1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659162 0.76 IMPDH2 (0.40) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL659991 0.74 KDM4E (0.35) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL25926086 0.74 GPR3 (0.44) HTTKDM4EALDH1A1GAAHPGD
SCHEMBL660127 0.73 KDM4E (0.40) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL11885002 0.70 KDM4E (0.44) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL27281841 0.69 HTT (0.40) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL29915122 0.69 KDM5A (0.38) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL27002302 0.69 KDM5A (0.38) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL657642 0.68 BRAF (0.42) HTTNCOA3KDM4EALDH1A1GLA
SCHEMBL658563 0.68 ALDH1A1 (0.49) HTTNCOA3KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 HTT 2445/4885NCOA3 1930/4885KDM4E 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.